The role of the proteasome in AML

Acute myeloid leukemia (AML) is deadly hematologic malignancy. Despite a well-characterized genetic and molecular landscape, targeted therapies for AML have failed to significantly improve clinical outcomes. Over the past decade, proteasome inhibition has been demonstrated to be an effective therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Csizmar, C M, Kim, D-H, Sachs, Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223148/
https://www.ncbi.nlm.nih.gov/pubmed/27911437
http://dx.doi.org/10.1038/bcj.2016.112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223148/
https://www.ncbi.nlm.nih.gov/pubmed/27911437
http://dx.doi.org/10.1038/bcj.2016.112

Ejemplares similares